About: Safety and Efficacy of Dolutegravir/Lamivudine (DTG/3TC) in Therapy-naive Human Immunodeficiency Virus-1 (HIV-1) Infected Adolescents

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Safety and Efficacy of Dolutegravir/Lamivudine (DTG/3TC) in Therapy-naive Human Immunodeficiency Virus-1 (HIV-1) Infected Adolescents Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	Safety and Efficacy of Dolutegravir/Lamivudine (DTG/3TC) in Therapy-naive Human Immunodeficiency Virus-1 (HIV-1) Infected Adolescents (en)
skos:prefLabel	Safety and Efficacy of Dolutegravir/Lamivudine (DTG/3TC) in Therapy-naive Human Immunodeficiency Virus-1 (HIV-1) Infected Adolescents (en)
name	Safety and Efficacy of Dolutegravir/Lamivudine (DTG/3TC) in Therapy-naive Human Immunodeficiency Virus-1 (HIV-1) Infected Adolescents (en)
title	wds:Q62054786-8873450A-9A9D-4F81-B850-A38692A38AD8
title	An Open-label, Single Arm Study to Evaluate the Week 48 Efficacy and Safety of a Two-drug Regimen of Dolutegravir/Lamivudine (DTG/3TC) as a Fixed Dose Combination (FDC), in Antiretroviral Therapy (ART)-Naive HIV-1-infected Adolescents, ≥12 to <18 Years of Age Who Weigh at Least 40 kg (en)
end time	wds:Q62054786-AEAB550D-CA97-4DF6-B8DC-58D352518DF1
end time	2020-07-31 00:00:00Z (xsd:dateTime)
instance of	wds:Q62054786-635671FC-83C0-49E1-A1C9-DE5D2B1A164E
instance of	clinical trial
start time	wds:Q62054786-2CB9878C-A731-4F85-979A-89C4FB14BEB4
start time	2018-10-29 00:00:00Z (xsd:dateTime)
research site	wds:Q62054786-A4AEA9A5-E7FC-4453-93ED-7C65BDDD87E0
research site	GSK
research intervention	wds:Q62054786-0A1ECB73-AF46-4098-AB1A-E0122C491A5B wds:Q62054786-7955454D-8109-45D6-BC5D-D26C4F7F72E9
research intervention	wd:Q422631 wd:Q937224
minimum age	wds:Q62054786-E63986DB-CA05-42F1-8E93-EF093FD29F33
minimum age	12 (xsd:decimal)
number of participants	wds:Q62054786-E3A0085C-1FA1-40A4-B2A7-46587B0C3E92
number of participants	30 (xsd:decimal)
maximum age	wds:Q62054786-9ED45356-4D65-47F1-90F2-E9D8137CF095
maximum age	17 (xsd:decimal)
study type	wds:Q62054786-C0635A9C-544C-424B-8252-19E7C7BB3A3D
study type	interventional study
ClinicalTrials.gov ID	wds:Q62054786-B86B2506-4A26-4477-B91E-383301052E3D
ClinicalTrials.gov ID	NCT03682848
clinical trial phase	wds:Q62054786-A4242D24-A627-428D-AD75-69529FEEAE58
clinical trial phase	phase III clinical trial
research subject recruitment status	wds:Q62054786-40E3AF72-66C0-4F03-8816-4032DEB8F2F1
research subject recruitment status	suspended
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q62054786

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software